TNF and graft versus host disease: We hypothesize that this increase in PTX3 plasma levels is likely triggered by massive ongoing production of inflammatory cytokines at peripheral sites, which precedes the observation of overt GvHD symptoms, including IL-1, and TNFα [27, 28], which are known to be potent inducers of PTX3 release.